Impact of reduced forced expiratory volume on cardiac prognosis in patients with chronic heart failure
- 157 Downloads
In patients with chronic heart failure (CHF), comorbidity of airflow limitation is associated with poor outcomes. The forced expiratory volume in 1 s (FEV1) is used to evaluate the severity of airflow limitation. However, the impact of FEV1 severity on prognosis has only been partially elucidated in patients with CHF. In total, 248 consecutive patients with CHF who successfully fulfilled spirometric measurement criteria were enrolled and prospectively followed. Percent predicted FEV1 (FEV1%predicted) was associated with the New York Heart Association Functional Classification. FEV1%predicted was significantly associated with diastolic dysfunction, evaluated using echocardiography; elevated inflammation markers; and increased pulmonary arterial pressure. There were 60 cardiac events, including 9 cardiac-related deaths and 51 re-hospitalizations due to the exacerbation of CHF during a follow-up period. Kaplan–Meier analysis revealed that the lowest FEV1%predicted group had the highest event rate, irrespective of the presence of smoking history. Multivariate Cox proportional hazard analysis showed that FEV1%predicted was an independent predictor of cardiac events after adjusting for confounders. The net reclassification improvement and integrated discrimination improvement were improved by the addition of FEV1%predicted to other cardiac risk factors. Decreased FEV1%predicted was independently associated with the poor cardiac outcomes in patients with CHF.
KeywordsAirflow limitation Chronic obstructive pulmonary disease FEV1%predicted Chronic heart failure
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 5.Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Aida Y, Nunomiya K, Sato M, Nakano H, Sato K, Nemoto T, Kimura T, Watanabe T, Konta T, Daimon M, Ueno Y, Kato T, Kayama T, Kubota I (2013) A lower level of forced expiratory volume in 1 s is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One 8:e83725CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 16:5–40CrossRefPubMedGoogle Scholar
- 11.(2004) Guideline of respiratory function tests–spirometry, flow-volume curve, diffusion capacity of the lung. Nihon Kokyuki Gakkai Zasshi Suppl 1–56Google Scholar
- 17.Park JE, Lyon AR, Shao D, Hector LR, Xu H, O’Gara P, Pinhu L, Chambers RC, Wort SJ, Griffiths MJ (2014) Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models. Thorax 69:1120–1127CrossRefPubMedGoogle Scholar
- 22.Ishikawa N, Hattori N, Kohno N, Kobayashi A, Hayamizu T, Johnson M (2015) Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls. Int J Chronic Obstr Pulm Dis 10:185–192Google Scholar
- 26.Oliveira MF, Arbex FF, Alencar MC, Souza A, Sperandio PA, Medeiros WM, Mazzuco A, Borghi-Silva A, Medina LA, Santos R, Hirai DM, Mancuso F, Almeida D, O’Donnell DE, Neder JA (2016) Heart failure impairs muscle blood flow and endurance exercise tolerance in COPD. COPD 13:407–415CrossRefPubMedGoogle Scholar